Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 14/08/2025

    Freezing brain tumor cells in a dormant state

    Every brain tumor is made up of cells in successive stages of activation. Researchers have now analyzed the individual structure of these activation pyramids in malignant brain tumors. In doing so, they discovered a signaling protein that slows down the transition from a dormant to an activated state by epigenetically reprogramming the cells. The hope is that this will permanently freeze cancer cells in a dormant state and thus halt tumor growth.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/freezing-brain-tumor-cells-dormant-state
  • Press release - 01/08/2025

    Early Pancreatic Cancer Detection

    Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new non-invasive diagnostic method designed by Fraunhofer researchers is set to make it possible to detect this aggressive form of cancer early on with high accuracy, significantly improving the prognosis for treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-pancreatic-cancer-detection
  • Press release - 01/08/2025

    A Less Debilitating Approach to Cancer Diagnosis

    Less radiation exposure during diagnosis and treatment for breast and lung cancer: New Fraunhofer method combines X-ray imaging and radar. In the MultiMed project, which explores multimodal medical imaging in 3D, researchers are developing a method that combines X-ray imaging and radar. It´s not only expected to improve the accuracy and efficacy of diagnosing, monitoring and treating breast and lung cancer but also lighten the burden on patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/less-debilitating-approach-cancer-diagnosis
  • Press release - 24/07/2025

    What makes cells migrate – and what can stop them

    Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body - not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an interesting candidate for potential future therapeutic approaches.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-makes-cells-migrate-and-what-can-stop-them
  • Press release - 23/07/2025

    Study finds caffeine can weaken effectiveness of certain antibiotics

    ngredients of our daily diet – including caffeine – can influence the resistance of bacteria to antibiotics. This has been shown in a new study by a team of researchers at the Universities of Tübingen and Würzburg. They discovered bacteria such as E. coli orchestrate complex regulatory cascades to react to chemical stimuli from their direct environment which can influence the effectiveness of antimicrobial drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/study-finds-caffeine-can-weaken-effectiveness-certain-antibiotics
  • Press release - 11/07/2025

    Molecular arms race: How the genome defends itself against internal enemies

    An international research team has deciphered a mechanism of evolutionary arms race in human cells. The findings provide insights into how mobile elements in DNA hijack cellular functions – and how cells can defend themselves against this in order to prevent conditions such as tumour formation or chronic inflammation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-arms-race-how-genome-defends-itself-against-internal-enemies
  • Press release - 10/07/2025

    Investigating kinase activity in living cells

    The ability of protein kinases to transfer a phosphate group to target proteins plays an important role in many cellular processes. Scientists at the Max Planck Institute for Medical Research have now developed a novel molecular tool that can monitor these kinase activities both spatially and temporally. This makes it possible to investigate the link between kinase activities and cellular phenotypes in heterogenous cell populations and in vivo.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/investigating-kinase-activity-living-cells
  • Press release - 09/07/2025

    The evolution of cancer cells decoded

    Cancer can take decades for cancer-promoting changes in the genome to eventually lead to the formation of a malignant tumor. Researchers at the German Cancer Research Center have now developed a method that allows for the first time to reconstruct the temporal development—the evolution—of cancerous cells from a single tissue sample.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/evolution-cancer-cells-decoded
  • Press release - 09/07/2025

    A new drug target for treating cancer and viral infections

    An international team of researchers led by Konstanz biologists has identified a molecular mechanism that regulates the activity of N-myristoyltransferases. This enzyme plays a role in biological signalling pathways, where dysregulation can lead to serious illness.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-drug-target-treating-cancer-and-viral-infections
  • Press release - 08/07/2025

    Five million euros for research into early cancer detection

    Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-million-euros-research-early-cancer-detection
  • Press release - 27/06/2025

    Felix Glang receives Otto Hahn Medal

    Felix Glang, of the Max Planck Institute for Biological Cybernetics in Tübingen, has been awarded the Otto Hahn Medal in recognition of his achievements in developing new magnetic resonance imaging (MRI) methods. Glang's methods enable clearer and faster brain scans.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/felix-glang-receives-otto-hahn-medal
  • Press release - 15/05/2025

    Ground-breaking ceremony for new Cyber Valley building in Stuttgart

    A building with 7400 m² of research space for robotics and artificial intelligence is being built on the Max Planck Campus in Büsnau. Researchers from the Max Planck Institute for Intelligent Systems (MPI-IS) and the University of Stuttgart will be working there with partners from science and industry as well as start-ups from 2027.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ground-breaking-ceremony-new-cyber-valley-building-stuttgart
  • Press release - 14/04/2025

    Brain waves in harmony

    The human brain continuously processes sensory impulses that compete for our attention. Our ability to select enables us to process specific information and ignore irrelevant stimuli. In this way, we can recognize a familiar face in a large crowd of people. But how is this made possible?

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/brain-waves-harmony
  • Press release - 14/03/2025

    Tool identifies specific viruses to combat dangerous bacteria

    University of Tübingen research team shortens the search for attackers that can wipe out multiresistant pathogens – with the aim of treating infections without antibiotics

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tool-identifies-specific-viruses-combat-dangerous-bacteria
  • Press release - 13/03/2025

    Dieter Schwarz Foundation provides long-term funding for application-oriented basic research and innovative talent pool

    The Max Planck Society and the Dieter Schwarz Foundation (DSS) have embarked on a groundbreaking initiative. On March 13, 2025, they signed an agreement through which the foundation will support an innovative approach by the Max Planck Institute for Medical Research in Heidelberg to translate basic research findings into practical applications. As part of this endeavour, two new departments of the institute will be established in Heilbronn.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dieter-schwarz-foundation-provides-long-term-funding-application-oriented-basic-research-and-innovative-talent-pool
  • Press release - 28/02/2025

    Recognise developmental disorders early with AI: Automatically classifying movement patterns in babies

    Using a new combination of three sensors and artificial intelligence, researchers at Heidelberg Medical Faculty of Heidelberg University and Heidelberg University Hospital are recognising patterns in babies' movements that show whether their nervous system is developing healthily.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/recognise-developmental-disorders-early-ai-automatically-classifying-movement-patterns-babies
  • Press release - 25/02/2025

    Self-healing hearts How Zebrafish regenerate heart muscle cells

    Zebrafish can completely replace damaged heart muscle cells: The affected organ becomes fully functional again. Researchers at Ulm University have discovered that a specific cell-to-cell communication signal helps them to cope better with replication stress. This stress inhibits tissue regeneration in humans and mammals as they age. In Zebrafish a signalling protein ensures that the cells of the damaged organ continue to divide and thus multiply.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/self-healing-hearts-how-zebrafish-regenerate-heart-muscle-cells
  • Press release - 25/02/2025

    Protein with contradictory properties: secret revealed

    A protein with contradictory properties: Despite its large negative surface charge, it has a strong tendency to take up electrons, which are also negatively charged. The researchers discovered positively charged calcium ions inside the protein very near the electrons, counteracting their charge. They see this as a natural way of handling opposing electrical charges and allowing the protein to optimally fulfill its biological function.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/protein-contradictory-properties-secret-revealed
  • Press release - 13/02/2025

    Guardian molecule keeps cells on track – new perspectives for the treatment of liver cancer

    A guardian molecule ensures that liver cells do not lose their identity. The discovery is of great importance for cancer medicine because a change of identity of cells has come into focus as a fundamental principle of carcinogenesis for several years. The research team was able to show that the newly discovered guardian is so powerful that it can slow down highly potent cancer drivers and cause malignant liver tumors to regress in mice.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guardian-molecule-keeps-cells-track-new-perspectives-treatment-liver-cancer
  • Project REVeyeVE - 06/02/2025 Es ist eine einzelne gedrehte, helle Struktur vor schwarzem Hintergrund zu sehen.

    Targeted, virus-free gene therapy for the eye using degradable nanopropellers

    Eye diseases that result in blindness in young people are primarily caused by genetic mutations. An interdisciplinary team of researchers from the Universities of Tübingen and Heidelberg is developing an innovative gene therapy method using biodegradable, magnetic nanopropellers. These innovative nanopropellers can effectively deliver intact genes into the affected cells, offering a potential solution for treating genetic disorders of this kind.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Targeted-virus-free-gene-therapy-for-the-eye-using-degradable-nanopropellers
  • Press release - 23/01/2025

    How the Ebola virus replicates in cells

    Like all viruses, the Ebola virus is dependent on host cells in order to replicate. Researchers at Heidelberg University Hospital, in collaboration with colleagues from the Friedrich Loeffler Institute, have been able to show for the first time using state-of-the-art imaging techniques how the replication compartments of the Ebola virus change during replication in infected cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-ebola-virus-replicates-cells
  • Press release - 17/01/2025

    The Minister President of Baden Wuerttemberg, Winfried Kretschmann, honors cutting-edge research at the Max Planck Institutes in Tübingen

    Winfried Kretschmann, the Minister President of Baden-Württemberg, Germany, visited the Max Planck Institutes for Biology Tübingen and Biological Cybernetics. During his tour, he commended the outstanding basic research in the natural sciences. He was particularly impressed by the innovative research projects spanning developmental and evolutionary biology, as well as neuroscience.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/minister-president-baden-wuerttemberg-winfried-kretschmann-honors-cutting-edge-research-max-planck-institutes-tubingen
  • Press release - 11/12/2024

    Top German research prize goes to Freiburg cancer researcher

    The Gottfried Wilhelm Leibniz-Prize 2025 goes to Prof. Dr Robert Zeiser for his outstanding research in haematology and immunology. Zeiser’s research at the University of Freiburg and the Medical Center – University of Freiburg have led, among other things, to new types of cancer therapy that has increased survival rates and the patients’ quality of life.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/top-german-research-prize-goes-freiburg-cancer-researcher
  • Press release - 14/11/2024

    Novel method for fighting tumors

    Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
  • Advancing quantum technology into real-world applications - 06/11/2024 Measurement setup with a quantum sensor.

    QSens: BMBF future cluster brings quantum sensors of the future into medicine

    The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.

    https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine

Page 1 / 5

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.gesundheitsindustrie-bw.de/en/search